N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one

C90H105N25O6S4 — CID 161320095

IUPACN-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one
SMILESCC1CN(c2nnnc3c2sc2nc(N4CCOCC4)c4c(c23)CCCC4)CCN1.COc1ccc(CNc2nnnc3c2sc2nc(N4CCOCC4)c4c(c23)CCCC4)cc1.O=c1[nH]nnc2c1sc1nc(N3CCOCC3)c3c(c12)CCCC3.c1cc(CN2CCCCC2)ccc1CNc1nnnc2c1sc1nc(N3CCOCC3)c3c(c12)CCCC3
InChIInChI=1S/C29H35N7OS.C24H26N6O2S.C21H27N7OS.C16H17N5O2S/c1-4-12-35(13-5-1)19-21-10-8-20(9-11-21)18-30-27-26-25(32-34-33-27)24-22-6-2-3-7-23(22)28(31-29(24)38-26)36-14-16-37-17-15-36;1-31-16-8-6-15(7-9-16)14-25-22-21-20(27-29-28-22)19-17-4-2-3-5-18(17)23(26-24(19)33-21)30-10-12-32-13-11-30;1-13-12-28(7-6-22-13)20-18-17(24-26-25-20)16-14-4-2-3-5-15(14)19(23-21(16)30-18)27-8-10-29-11-9-27;22-15-13-12(18-20-19-15)11-9-3-1-2-4-10(9)14(17-16(11)24-13)21-5-7-23-8-6-21/h8-11H,1-7,12-19H2,(H,30,32,33);6-9H,2-5,10-14H2,1H3,(H,25,27,28);13,22H,2-12H2,1H3;1-8H2,(H,18,19,22)
InChIKeyVKAIOCJFSVPOQU-UHFFFAOYSA-N
MW1761.27 g/mol
LogP12.71
Rot. Bonds14

About N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one

N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one (PubChem CID 161320095) has the molecular formula C90H105N25O6S4 and a molecular weight of 1761.27 g/mol. Its IUPAC name is N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one.

Molecular Properties

Compound NameN-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one
PubChem CID161320095
Molecular FormulaC90H105N25O6S4
Molecular Weight1761.27 g/mol
Exact Mass1759.76
IUPAC NameN-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one
SMILESCC1CN(c2nnnc3c2sc2nc(N4CCOCC4)c4c(c23)CCCC4)CCN1.COc1ccc(CNc2nnnc3c2sc2nc(N4CCOCC4)c4c(c23)CCCC4)cc1.O=c1[nH]nnc2c1sc1nc(N3CCOCC3)c3c(c12)CCCC3.c1cc(CN2CCCCC2)ccc1CNc1nnnc2c1sc1nc(N3CCOCC3)c3c(c12)CCCC3
InChIInChI=1S/C29H35N7OS.C24H26N6O2S.C21H27N7OS.C16H17N5O2S/c1-4-12-35(13-5-1)19-21-10-8-20(9-11-21)18-30-27-26-25(32-34-33-27)24-22-6-2-3-7-23(22)28(31-29(24)38-26)36-14-16-37-17-15-36;1-31-16-8-6-15(7-9-16)14-25-22-21-20(27-29-28-22)19-17-4-2-3-5-18(17)23(26-24(19)33-21)30-10-12-32-13-11-30;1-13-12-28(7-6-22-13)20-18-17(24-26-25-20)16-14-4-2-3-5-15(14)19(23-21(16)30-18)27-8-10-29-11-9-27;22-15-13-12(18-20-19-15)11-9-3-1-2-4-10(9)14(17-16(11)24-13)21-5-7-23-8-6-21/h8-11H,1-7,12-19H2,(H,30,32,33);6-9H,2-5,10-14H2,1H3,(H,25,27,28);13,22H,2-12H2,1H3;1-8H2,(H,18,19,22)
InChIKeyVKAIOCJFSVPOQU-UHFFFAOYSA-N
XLogP12.71
TPSA327.89 Ų
H-Bond Donors4
H-Bond Acceptors34
Rotatable Bonds14
Heavy Atoms125
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001761.27
LogP ≤ 512.71
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1034

Analyze N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-(4-chloro-6-piperidin-1-yl-8-thia-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-11-yl)morpholine;N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-methoxy-11-phenyl-6-piperidin-1-yl-8-thia-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;6-piperidin-1-yl-8-thia-3,4,5,10-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene
CID 158820108
N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-methoxy-11-phenyl-6-piperazin-1-yl-8-thia-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one;6-piperazin-1-yl-8-thia-3,4,5,10-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene
CID 159106292
3-amino-N-[(3R)-7-[(3S,4S)-3-amino-4-methoxypiperidin-1-yl]-3,4-dihydro-2H-chromen-3-yl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide;3-amino-N-[(3R)-7-[(3R,4R)-3-amino-4-methoxypiperidin-1-yl]-3,4-dihydro-2H-chromen-3-yl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide;3-amino-N-[(6S)-2-[(3S,4S)-3-amino-4-methoxypiperidin-1-yl]-5,6,7,8-tetrahydroquinolin-6-yl]-6-methylthieno[2,3-b]pyridine-2-carboxamide;3-amino-N-[(6S)-2-[(3R,4R)-3-amino-4-methoxypiperidin-1-yl]-5,6,7,8-tetrahydroquinolin-6-yl]-6-methylthieno[2,3-b]pyridine-2-carboxamide
CID 167537291

Frequently Asked Questions

What is the IUPAC name of N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one?
The IUPAC name of N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one (CID 161320095) is N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one.
What is the SMILES notation for N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one?
The canonical SMILES for N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one is CC1CN(c2nnnc3c2sc2nc(N4CCOCC4)c4c(c23)CCCC4)CCN1.COc1ccc(CNc2nnnc3c2sc2nc(N4CCOCC4)c4c(c23)CCCC4)cc1.O=c1[nH]nnc2c1sc1nc(N3CCOCC3)c3c(c12)CCCC3.c1cc(CN2CCCCC2)ccc1CNc1nnnc2c1sc1nc(N3CCOCC3)c3c(c12)CCCC3.
What is the InChIKey of N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one?
The InChIKey is VKAIOCJFSVPOQU-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H35N7OS.C24H26N6O2S.C21H27N7OS.C16H17N5O2S/c1-4-12-35(13-5-1)19-21-10-8-20(9-11-21)18-30-27-26-25(32-34-33-27)24-22-6-2-3-7-23(22)28(31-29(24)38-26)36-14-16-37-17-15-36;1-31-16-8-6-15(7-9-16)14-25-22-21-20(27-29-28-22)19-17-4-2-3-5-18(17)23(26-24(19)33-21)30-10-12-32-13-11-30;1-13-12-28(7-6-22-13)20-18-17(24-26-25-20)16-14-4-2-3-5-15(14)19(23-21(16)30-18)27-8-10-29-11-9-27;22-15-13-12(18-20-19-15)11-9-3-1-2-4-10(9)14(17-16(11)24-13)21-5-7-23-8-6-21/h8-11H,1-7,12-19H2,(H,30,32,33);6-9H,2-5,10-14H2,1H3,(H,25,27,28);13,22H,2-12H2,1H3;1-8H2,(H,18,19,22).
What are the key properties of N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one?
N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one has a molecular weight of 1761.27 g/mol, XLogP of 12.71, 14 rotatable bonds, 4 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4-methoxyphenyl)methyl]-8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;4-[13-(3-methylpiperazin-1-yl)-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-8-yl]morpholine;8-morpholin-4-yl-N-[[4-(piperidin-1-ylmethyl)phenyl]methyl]-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-amine;8-morpholin-4-yl-11-thia-9,14,15,16-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),15-pentaen-13-one is sourced from PubChem (CID 161320095), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).